The previous in vivo study used A549 lung cancer tumors with genetically lowered Nrf2 expression, which sensitized cancer cells to cisplatin/carboplatin pro-apoptotic effects in nude mice [37]. This evidence concerns the gene NFE2L2 and lung cancer.